The potential role of soyfoods in weight and adiposity reduction: An evidence-based review

Obesity Reviews

Volumn 9, Issue 3, 2008, Pages 219-235

  Cope, M B ^a   Erdman Jr , J W ^b   Allison, D B ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adiposity; Obesity; Soyfoods; Weight loss

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

CALORIC INTAKE; EVIDENCE BASED PRACTICE; FOOD INTAKE; HUMAN; IN VITRO STUDY; NONHUMAN; OBESITY; REVIEW; RISK FACTOR; SEX DIFFERENCE; SOYBEAN; WEIGHT; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; CLINICAL TRIALS AS TOPIC; DIET; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; HUMANS; SOY FOODS; WEIGHT LOSS;

EID: 42449125290     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2007.00390.x     Document Type: Review

References (91)

1. Friedman M, Brandon DL. Nutritional and health benefits of soy proteins. J Agric Food Chem 2001 49 : 1069 1086.
2. Omoni AO, Aluko RE. Soybean foods and their benefits: potential mechanisms of action. Nutr Rev 2005 63 : 272 283.
3. Food and Drug Administration. Food labeling, health claims, soyprotein, and coronary heart disease. Fed Reg 1999 57 : 699 733.
4. Sacks FM, Lichtenstein A, Van Horn L, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006 113 : 1034 1044.
5. Lee M, Kim I. Soy protein and obesity. Nutrition 2000 16 : 459 460.
6. Aoyama T, Fukui K, Takamatsu K, Hashimoto Y, Yamamoto T. Soy protein isolate and its hydrolysate reduce body fat of dietary obese rats and genetically obese mice (yellow KK). Nutrition 2000 16 : 349 354.
7. Kim HK, Nelson-Dooley C, Della-Fera MA, Yang JY, Zhang W, Duan JH, Hartzell DL, Hamrick MW, Baile CA. Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice. J Nutr 2006 136 : 409 414.
8. Wu J, Wang X, Chiba H, Higuchi M, Nakatani T, Ezaki O et al. Combined intervention of soy isoflavone and moderate exercise prevents body fat elevation and bone loss in ovariectomized mice. Metabolism 2004 53 : 942 948.
9. Allison DB, Gadbury G, Schwartz LG, Murugesan R, Kraker JL, Heshka S, Fontaine KR, Heymsfield SB. A novel soy-based meal replacement formula for weight loss among obese individuals: a randomized controlled clinical trial. Eur J Clin Nutr 2003 57 : 514 522.
10. Anderson JW, Hoie LH. Weight loss and lipid changes with low-energy diets: comparator study of milk-based versus soy-based liquid meal replacement interventions. J Am Coll Nutr 2005 24 : 210 216.
11. Deibert P, Konig D, Schmidt-Trucksaess A, Zaenker KS, Frey I, Landmann U, Berg A. Weight loss without losing muscle mass in pre-obese and obese subjects induced by a high-soy-protein diet. Int J Obes Relat Metab Disord 2004 28 : 1349 1352.
12. Li Z, Hong K, Saltsman P, DeShields S, Bellman M, Thames G, Liu Y, Wang HJ, Elashoff R, Heber D. Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr 2005 59 : 411 418.
13. Liu K, Hettiarachchy N, Kalapathy U, Messina MJ, Proctor A. Soybeans Chemistry. Technology, and Utilization. Chapman & Hall : New York, 1997.
14. Young VR. Soy protein in relation to human protein and amino acid nutrition. J Am Diet Assoc 1991 91 : 828 835.
15. Foti P, Erba D, Riso P, Spadafranca A, Criscuoli F, Testolin G. Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes. Arch Biochem Biophys 2005 433 : 421 427.
16. Xu X, Duncan AM, Wangen KE, Kurzer MS. Soy consumption alters endogenous estrogen metabolism in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2000 9 : 781 786.
17. Greaves KA, Wilson MD, Rudel LL, Williams JK, Wagner JD. Consumption of soy protein reduces cholesterol absorption compared to casein protein alone or supplemented with an isoflavone extract or conjugated equine estrogen in ovariectomized cynomolgus monkeys. J Nutr 2000 130 : 820 826.
18. Potter SM. Overview of proposed mechanisms for the hypocholesterolemic effect of soy. J Nutr 1995 125 : 606S 611S.
19. Hanson LN, Engelman HM, Alekel DL, Schalinske KL, Kohut ML, Reddy MB. Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women. Am J Clin Nutr 2006 84 : 774 780.
20. Lukaczer D, Liska DJ, Lerman RH, Darland G, Schiltz B, Tripp M, Bland JS. Effect of a low glycemic index diet with soy protein and phytosterols on CVD risk factors in postmenopausal women. Nutrition 2006 22 : 104 113.
21. Normen L, Dutta P, Lia A, Andersson H. Soy sterol esters and beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel. Am J Clin Nutr 2000 71 : 908 913.
22. Erdman JW Jr., Badger TM, Lampe JW, Setchell KD, Messina M. Not all soy products are created equal: caution needed in interpretation of research results. J Nutr 2004 134 : 1229S 1233S.
23. Erdman JW Jr. AHA Science Advisory: soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition Committee of the AHA. Circulation 2000 102 : 2555 2559.
24. Lamartiniere CA. Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr 2000 71 : 1705S 1707S.
25. Sarkar FH, Li Y. Soy isoflavones and cancer prevention. Cancer Invest 2003 21 : 744 757.
26. Pollard M, Wolter W. Prevention of spontaneous prostate-related cancer in Lobund-Wistar rats by a soy protein isolate/isoflavone diet. Prostate 2000 45 : 101 105.
27. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, Clinton SK. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 1999 129 : 1628 1635.
28. Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 2000 72 : 844 852.
29. Ho SC, Woo J, Lam S, Chen Y, Sham A, Lau J. Soy protein consumption and bone mass in early postmenopausal Chinese women. Osteoporos Int 2003 14 : 835 842.
30. Kim MS, Lee YS. Effects of soy isoflavone and/or estrogen treatments on bone metabolism in ovariectomized rats. J Med Food 2005 8 : 439 445.
31. Manzoni MS, Rossi EA, Carlos IZ, Vendramini RC, Duarte AC, Damaso AR. Fermented soy product supplemented with isoflavones affected fat depots in juvenile rats. Nutrition 2005 21 : 1018 1024.
32. Anderson JW, Luan J, Hoie LH. Structured weight-loss programs: meta-analysis of weight loss at 24 weeks and assessment of effects of intervention intensity. Adv Ther 2004 21 : 61 75.
33. Fontaine KR, Yang D, Gadbury GL, Heshka S, Schwartz LG, Murugesan R, Kraker JL, Heo M, Heymsfield SB, Allison DB. Results of soy-based meal replacement formula on weight, anthropometry, serum lipids & blood pressure during a 40-week clinical weight loss trial. Nutr J 2003 2 : 14.
34. Banz WJ, Davis J, Peterson R, Iqbal MJ. Gene expression and adiposity are modified by soy protein in male Zucker diabetic fatty rats. Obes Res 2004 12 : 1907 1913.
35. McKee J, Warber SL. Integrative therapies for menopause. South Med J 2005 98 : 319 326.
36. Hwang JT, Park IJ, Shin JI, Lee YK, Lee SK, Baik HW, Ha J, Park OJ. Genistein, EGC G, and capsaicin inhibit adipocyte differentiation process via activating AMP-activated protein kinase. Biochem Biophys Res Commun 2005 338 : 694 699.
37. Harmon AW, Harp JB. Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am J Physiol Cell Physiol 2001 280 : C807 C813.
38. Harmon AW, Patel YM, Harp JB. Genistein inhibits CCAAT/enhancer-binding protein beta (C/EBPbeta) activity and 3T3-L1 adipogenesis by increasing C/EBP homologous protein expression. Biochem J 2002 367 : 203 208.
39. Barnes S, Sfakianos J, Coward L, Kirk M. Soy isoflavonoids and cancer prevention. Underlying biochemical and pharmacological issues. Adv Exp Med Biol 1996 401 : 87 100.
40. Aoyama T, Fukui K, Nakamori T, Hashimoto Y, Yamamoto T, Takamatsu K, Sugano M. Effect of soy and milk whey protein isolates and their hydrolysates on weight reduction in genetically obese mice. Biosci Biotechnol Biochem 2000 64 : 2594 2600.
41. Moriyama T, Kishimoto K, Nagai K, Urade R, Ogawa T, Utsumi S, Maruyama N, Maebuchi M. Soybean beta-conglycinin diet suppresses serum triglyceride levels in normal and genetically obese mice by induction of beta-oxidation, downregulation of fatty acid synthase, and inhibition of triglyceride absorption. Biosci Biotechnol Biochem 2004 68 : 352 359.
42. Nagasawa A, Fukui K, Funahashi T, Maeda N, Shimomura I, Kihara S, Waki M, Takamatsu K, Matsuzawa Y. Effects of soy protein diet on the expression of adipose genes and plasma adiponectin. Horm Metab Res 2002 34 : 635 639.
43. Iritani N, Hosomi H, Fukuda H, Tada K, Ikeda H. Soybean protein suppresses hepatic lipogenic enzyme gene expression in Wistar fatty rats. J Nutr 1996 126 : 380 388.
44. Nagasawa A, Fukui K, Kojima M, Kishida K, Maeda N, Nagaretani H, Hibuse T, Nishizawa H, Kihara S, Waki M, Takamatsu K, Funahashi T, Matsuzawa Y. Divergent effects of soy protein diet on the expression of adipocytokines. Biochem Biophys Res Commun 2003 311 : 909 914.
45. Naaz A, Yellayi S, Zakroczymski MA, Bunick D, Doerge DR, Lubahn DB, Helferich WG, Cooke PS. The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology 2003 144 : 3315 3320.
46. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia 2000 43 : 1498 1506.
47. Morifuji M, Sanbongi C, Sugiura K. Dietary soya protein intake and exercise training have an additive effect on skeletal muscle fatty acid oxidation enzyme activities and mRNA levels in rats. Br J Nutr 2006 96 : 469 475.
48. Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA, Shay N. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 2003 133 : 1238 1243.
49. Dolinoy DC, Weidman JR, Waterland RA, Jirtle RL. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 2006 114 : 567 572.
50. Yang G, Shu XO, Jin F, Elasy T, Li HL, Li Q, Huang F, Zhang XL, Gao YT, Zheng W. Soyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women's Health Study. Eur J Clin Nutr 2004 58 : 615 620.
51. Guthrie JR, Ball M, Murkies A, Dennerstein L. Dietary phytoestrogen intake in mid-life Australian-born women: relationship to health variables. Climacteric 2000 3 : 254 261.
52. Ikeda Y, Iki M, Morita A, Kajita E, Kagamimori S, Kagawa Y, Yoneshima H. Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese Population-Based Osteoporosis (JPOS) Study. J Nutr 2006 136 : 1323 1328.
53. Nachtigal MC, Patterson RE, Stratton KL, Adams LA, Shattuck AL, White E. Dietary supplements and weight control in a middle-age population. J Altern Complement Med 2005 11 : 909 915.
54. Goodman-Gruen D, Kritz-Silverstein D. Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 2001 131 : 1202 1206.
55. Yamori Y. Worldwide epidemic of obesity: hope for Japanese diets. Clin Exp Pharmacol Physiol 2004 31 : S2 S4.
56. Bosello O, Cominacini L, Zocca I, Garbin U, Compri R, Davoli A, Brunetti L. Short- and long-term effects of hypocaloric diets containing proteins of different sources on plasma lipids and apoproteins of obese subjects. Ann Nutr Metab 1988 32 : 206 214.
57. Yamashita T, Sasahara T, Pomeroy SE, Collier G, Nestel PJ. Arterial compliance, blood pressure, plasma leptin, and plasma lipids in women are improved with weight reduction equally with a meat-based diet and a plant-based diet. Metabolism 1998 47 : 1308 1314.
58. Anderson JW, Fuller J, Patterson K, Blair R, Tabor A. Soy compared to casein meal replacement shakes with energy-restricted diets for obese women: randomized controlled trial. Metabolism 2007 56 : 280 288.
59. Kohno M, Hirotsuka M, Kito M, Matsuzawa Y. Decreases in Serum Triacyglycerol and Visceral Fat Mediated by Dietary Soybean beta-conglycinin. J Atherosc Thromb 2006 13 : 247 255.
60. Mikkelsen PB, Toubro S, Astrup A. Effect of fat-reduced diets on 24-h energy expenditure: comparisons between animal protein, vegetable protein, and carbohydrate. Am J Clin Nutr 2000 72 : 1135 1141.
61. Semon BA, Leung PM, Rogers QR, Gietzen DW. Effect of type of protein on food intake of rats fed high protein diets. Physiol Behav 1987 41 : 451 458.
62. Lang V, Bellisle F, Alamowitch C, Craplet C, Bornet FR, Slama G, Guy-Grand B. Varying the protein source in mixed meal modifies glucose, insulin and glucagon kinetics in healthy men, has weak effects on subjective satiety and fails to affect food intake. Eur J Clin Nutr 1999 53 : 959 965.
63. Anderson GH, Tecimer SN, Shah D, Zafar TA. Protein source, quantity, and time of consumption determine the effect of proteins on short-term food intake in young men. J Nutr 2004 134 : 3011 3015.
64. Williamson DA, Geiselman PJ, Lovejoy J, Greenway F, Volaufova J, Martin CK, Arnett C, Ortego L. Effects of consuming mycoprotein, tofu or chicken upon subsequent eating behaviour, hunger and safety. Appetite 2006 46 : 41 48.
65. Reynolds K, Chin A, Lees KA, Nguyen A, Bujnowski D, He J. A meta-analysis of the effect of soy protein supplementation on serum lipids. Am J Cardiol 2006 98 : 633 640.
66. Bhathena SJ, Velasquez MT. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 2002 76 : 1191 1201.
67. Vedavanam K, Srijayanta S, O'Reilly J, Raman A, Wiseman H. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res 1999 13 : 601 608.
68. Sorenson RL, Brelje TC, Roth C. Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion. Endocrinology 1994 134 : 1975 1978.
69. Liu D, Zhen W, Yang Z, Carter JD, Si H, Reynolds KA. Genistein acutely stimulates insulin secretion in pancreatic beta-cells through a cAMP-dependent protein kinase pathway. Diabetes 2006 55 : 1043 1050.
70. Mackowiak P, Nogowski L, Nowak KW. Effect of isoflavone genistein on insulin receptors in perfused liver of ovariectomized rats. J Recept Signal Transduct Res 1999 19 : 283 292.
71. Abler A, Smith JA, Randazzo PA, Rothenberg PL, Jarett L. Genistein differentially inhibits postreceptor effects of insulin in rat adipocytes without inhibiting the insulin receptor kinase. J Biol Chem 1992 267 : 3946 3951.
72. Szkudelska K, Nogowski L, Szkudelski T. Genistein affects lipogenesis and lipolysis in isolated rat adipocytes. J Steroid Biochem Mol Biol 2000 75 : 265 271.
73. Szkudelski T, Nogowski L, Pruszynska-Oszmalek E, Kaczmarek P, Szkudelska K. Genistein restricts leptin secretion from rat adipocytes. J Steroid Biochem Mol Biol 2005 96 : 301 307.
74. Hurley C, Richard D, Deshaies Y, Jacques H. Soy protein isolate in the presence of cornstarch reduces body fat gain in rats. Can J Physiol Pharmacol 1998 76 : 1000 1007.
75. Lavigne C, Marette A, Jacques H. Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 2000 278 : E491 E500.
76. Iritani N, Sugimoto T, Fukuda H, Komiya M, Ikeda H. Dietary soybean protein increases insulin receptor gene expression in Wistar fatty rats when dietary polyunsaturated fatty acid level is low. J Nutr 1997 127 : 1077 1083.
77. Dyrskog SE, Jeppesen PB, Colombo M, Abudula R, Hermansen K. Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats. Metabolism 2005 54 : 1181 1188.
78. Hall WL, Vafeiadou K, Hallund J, Bugel S, Reimann M, Koebnick C, Zunft HJ, Ferrari M, Branca F, Dadd T, Talbot D, Powell J, Minihane AM, Cassidy A, Nilsson M, Dahlman-Wright K, Gustafsson JA, Williams CM. Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 2006 83 : 592 600.
79. Cheng SY, Shaw NS, Tsai KS, Chen CY. The hypoglycemic effects of soy isoflavones on postmenopausal women. J Womens Health (Larchmt) 2004 13 : 1080 1086.
80. Ali AA, Velasquez MT, Hansen CT, Mohamed AI, Bhathena SJ. Effects of soybean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. J Nutr Biochem 2004 15 : 583 590.
81. Crouse JR III, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasmaconcentrations of lipids and lipoproteins. Arch Intern Med 1999 159 : 2070 2076.
82. Jenkins DJ, Kendall CW, Marchie A, Faulkner D, Vidgen E, Lapsley KG, Trautwein EA, Parker TL, Josse RG, Leiter LA, Connelly PW. The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia. Metabolism 2003 52 : 1478 1483.
83. Gardner CD, Newell KA, Cherin R, Haskell WL. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am J Clin Nutr 2001 73 : 728 735.
84. Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS. Probiotic consumption does not enhance the cholesterol-lowering effect of soy in postmenopausal women. J Nutr 2004 134 : 3277 3283.
85. Ryokkynen A, Kukkonen JV, Nieminen P. Effects of dietary genistein on mouse reproduction, postnatal development and weight-regulation. Anim Reprod Sci 2006 93 : 337 348.
86. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998 68 : 1375S 1379S.
87. Hidaka S, Okamoto Y, Miyazaki K, Uesugi T. Evaluation of a soybean product fujiflavone P40 as an antiosteoporotic agent in rats. Phytother Res 2003 17 : 112 119.
88. Ashton E, Ball M. Effects of soy as tofu vs meat on lipoprotein concentrations. Eur J Clin Nutr 2000 54 : 14 19.
89. Anderson JW, Blake JE, Turner J, Smith BM. Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr 1998 68 : 1347S 1353S.
90. Mori M, Aizawa T, Tokoro M, Miki T, Yamori Y. Soy isoflavone tablets reduce osteoporosis risk factors and obesity in middle-aged Japanese women. Clin Exp Pharmacol Physiol 2004 31 : S39 S41.
91. Yalcin AS. Emerging therapeutic potential of whey proteins and peptides. Curr Pharm Des 2006 12 : 1637 1643.